Decisions on Non-oncology Breakthrough Therapy Designation Requests in 2017-2019.
Atasi PoddarMiranda RaggioJohn ConcatoPublished in: Therapeutic innovation & regulatory science (2023)
This analysis describes CDER's decision-making process related to review of requests for breakthrough therapy designations and enhances public awareness regarding efforts to expedite drug development.